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Mastocytosis represents a spectrum of disease variants 
characterized by a pathologic increase of mast cells in 
cutaneous and extracutaneous tissue. Most commonly, the 
infiltration site of mast cells is skin but, extracutaneous sites 
including the bone marrow, gastrointestinal tract, liver, spleen 
and lymphoid tissue have been reported [1]. Patients with 
mastocytosis have a risk of perioperative reactions via mast 
cell degranulation and sometimes catastrophic cardiovascular 
collapse during anesthesia is also possible [2]. We describe 
the anesthetic management in a pediatric patient with 
mastocytosis. 
A 5-year-old male (weight, 16.5 kg) was admitted for 
elective tonsillectomy and adenoidectomy. He had a history 
of mastocytosis diagnosed by his dermatologist 3 years ago. 
He had brownish patches and erythematous urticaria with 
itching on the whole body from infancy. Serum IgE level using 
a paper radioimmunosorbent test (PRIST) was 212.54 IU/
ml (normal value 1-183 IU/ml). Mast cells were present as 
determined by toluidine blue staining of a skin punch biopsy 
from the abdomen. He had a hoarseness and a hypertrophied 
tonsil. He took mequitazine, ketotifen fumarate, hydroxyzine 
hydrochloride for maintenance therapy and also received 
medications on the morning of the surgery. He had no 
other history of medical illness except the mastocytosis and 
his preoperative laboratory tests were normal. He was not 
premedicated (except for maintenance therapy) and upon 
arrival to the operating room, his vital signs were: blood 
pressure at 100/70 mmHg, heart rate at 130 beats/min and 
pulse oximetry at 99% before anesthetic induction. Anesthesia 
was induced with propofol (30 mg), rocuronium (10 mg) and 
alfentanil (200 μg). Tracheal intubation was performed using 
a single lumen, 4.5 mm internal diameter tube in one attempt 
without difficulty. Anesthesia was maintained with sevoflurane 
at 2-3 vol%. The tonsillectomy and adenoidectomy proceeded 
without an event. At the end of surgery, all anesthetic agents 
were discontinued and the residual neuromuscular blockade 
was reversed with pyridostigmine and glycopyrrolate. The 
tracheal tube was removed when the patient responded to 
verbal commands and there was sufficient spontaneous 
respiration and neuromuscular function. There were no signs 
of reactive airway. The patient remained in the post-anesthetic 
care unit for 30 minutes event free and was then transferred 
to the general ward. He had an uneventful recovery and was 
discharged on postoperative day 2.
Mast cell intracytoplasic granules contain proinflammatory 
cytokines and stimulations such as pressure, drugs and 
allergens may trigger the release of those substances. 
Symptoms including recurrent hypotension, tachycardia and 
cardiovascular collapse may develop even with the cutaneous 
form of mastocytosis [3]. 
Although the drugs used in the perioperative period 
may directly or indirectly activate mast cells, preoperative 
allergy skin tests to drugs used during anesthesia are not 
recommended. Skin test may not reliable predictors of adverse 
reactions to drugs because their metabolites are sometimes 
responsible for the allergic reaction and not the drug itself 
[4]. Trigger factors could avoid incremental use of mediator-
targeting drugs such as H1 and H2 blockers. Sometimes, mast 
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cell stabilizers like sodium cromoglycate or glucocorticoids 
might be beneficial in the case of abdominal cramping or 
cardiovascular symptoms [5]. However, routine prophylactic 
anti-histamine and steroids were not used. Instead, when 
patients were taking chronic therapy, their medications were 
continued as scheduled as previously reported in the anesthetic 
management of 29 procedures [4]. Further, that study, there 
were no obvious restrictions of anesthetic agents and no serious 
complications were reported [4]. 
Pediatric patients with mastocytosis often need diagnostic 
and therapeutic procedures that require general anesthesia. 
Because mast cells are implicated in the pathophysiology of 
anaphylaxis, drugs used in anesthesia which may degranulate 
mast cells raise concerns about the potential for adverse 
reactions in patients with mastocytosis. Although routine 
anesthetic techniques are not necessarily warranted, an 
understanding of the anesthetic implications of the disease 
and meticulous preparation to treat possible adverse events are 
advised.
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